N-methyl-D-aspartate receptor glycine site (NMDAR glycine site) (NMDAR glycine site)

The N-methyl-D-aspartate receptor glycine site is a mandatory co-agonist binding site located on the GluN1 subunit of the NMDA receptor complex (UniProt: P17342). It is distinct from the glutamate binding site and must be occupied by glycine or D-serine for the receptor's ion channel to open upon glutamate stimulation (Kleckner & Dingledine, 1988). This site is a key regulator of excitatory neurotransmission and synaptic plasticity, which are essential for cognitive functions like learning and memory (Paoletti et al., 2013). In pathology, NMDA receptor hypofunction—often involving reduced occupancy of the glycine site—is a central hypothesis in the development of schizophrenia symptoms (Javitt, 2006). Therapeutic strategies include using partial agonists like D-cycloserine to enhance receptor function in psychiatric disorders or using antagonists to prevent excitotoxic neuronal death in conditions like stroke (Lees et al., 2000). Despite its potential, drug development has faced challenges, including the narrow therapeutic window of agonists and the clinical failure of several high-profile antagonists in acute neuroprotection trials.

Other names

GlycineB siteStrychnine-insensitive glycine binding siteGluN1 glycine binding siteNMDA receptor co-agonist site

The mechanism involves the binding of ligands to the GluN1 subunit of the NMDA receptor, which acts as an obligatory co-agonist site; agonists facilitate while antagonists inhibit the glutamate-induced opening of the ion channel.